Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas

Blood

Volumn 88, Issue 1, 1996, Pages 242-251

  Kingma, D W ^a   Weiss, W B ^b   Jaffe, E S ^b   Kumar, S ^b   Frekko, K ^b   Raffeld, M ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BURKITT LYMPHOMA; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN SITU HYBRIDIZATION; INFANT; LYMPHOID HYPERPLASIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS LATENCY; VIRUS ONCOGENE;

EID: 0029900822     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.242.bloodjournal881242     Document Type: Article

References (45)

1. Wu T, Mann R, Epstein J, MacMahon E, Lee W, Charache P, Hayward S, Kurman R, Hayward G, Ambinder R: Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. Am J Pathol 138:1461, 1991
2. Weiss L, Movahed L, Butler A, Swanson S, Frierson H, Cooper P, Colby T, Mills S: Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization. Am J Surg Pathol 13:625, 1989
3. Magrath I, Jain V, Bhatia K: Epstein-Barr virus and Burkitt's lymphoma. Cancer Biology 3:285, 1992
4. Schaefer B, Woisetschlaeger M, Strominger J, Speck S: Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter distinct from the promoters used in latently infected lymphocytes. Proc Natl Acad Sci USA 88:6550, 1991
5. Epstein M, Achong B: Various forms of Epstein-Barr virus infection in man: Established facts and a general concept. Lancet 2:836, 1973
6. Kingma D, Medeiros L, Barletta J, Raffeld M, Mann R, Ambinder R, Jaffe E: Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol 18:48, 1994
7. Ambinder R, Browning P, Lorenzana I, Leventhal B, Cosenza H, Mann R, MacMahon E, Medina R, Cardona V, Grufferman S, Olshan A, Levin A, Petersen E, Blattner W, Levine P: Epstein-Barr virus in childhood Hodgkin's disease in Honduras and the United States. Blood 81:462, 1993
8. Chang K, Albujar P, Chen Y, Johnson R, Weiss L: High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 2:496, 1993
9. Weiss L, Chen Y, Liu X, Shibata D: Epstein-Barr virus and Hodgkin's disease: A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139:1259, 1991
10. Hollingsworth H, Stetler-Stevenson M, Gagneten D, Kingma D, Raffeld M, Jaffe E: Immunodeficiency-associated malignant lymphoma: Three cases showing genotypic evidence of both T- and B-cell lineages. Am J Surg Pathol 18:1092, 1994
11. Kumar S, Kumar D, Kingma D, Jaffe E: Epstein-Barr virus-associated T-cell lymphoma in a renal transplant patient. Am J Surg Pathol 17:1046, 1993
12. Harrington D, Weisenburger D, Purtilo D: Biology of disease: Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 67:5, 1992
13. d'Amore E, Manivel C, Gajl-Peczalska K, Litz C, Copenhaver C, Shapiro R, Strickler J: B-cell lymphoproliferative disorders after bone marrow transplant: An analysis of ten cases with emphasis on Epstein-Barr virus detection by in situ hybridization. Cancer 68:1285, 1991
14. Katz B, Raab-Traub N, Miller G: Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis 160:589, 1989
15. Sullivan J: Epstein-Barr virus and lymphoproliferative disorders. Semin Hematol 25:269, 1988
16. Hamilton-Dutoit S, Raphael M, Audouin J, Diebold J, Lisse I, Pedersen C, Oksenhendler E, Marelle L, Pallesen G: In situ demonstration of Epstein-Barr virus small RNAs (EBER1) in acquired immunodeficiency syndrome-related lymphomas: Correlation with tumor morphology and primary site. Blood 82:619, 1993
17. Hamilton-Dutoit S, Rea D, Raphael M, Sandvej K, Delecluse H, Gisselbrecht C, Marelle L, van Krieken J, Pallesen G: Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma: Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 143:1072, 1993
18. Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M: Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 11:1674, 1993
19. Boyle M, Sculley T, Penny R, Sewell W, Tschuchnigg M, Berger M, Cooper D: The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphoma. Leuk Lymphoma 10:17, 1993
20. Klein G: Viral latency and transformation: The strategy of Epstein-Barr virus. Cell 58:5, 1989
21. Kerr B, Lear A, Rowe M, Croom-Carter D, Young L, Rookes S, Gallimore P, Rickenson A: Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promotor usage. Virology 187:189, 1992
22. Fahraeus R, Fu H, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B: Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42:329, 1988
23. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831, 1985
24. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B-cells from programmed cell death. Cell 65:1107, 1991
25. Moorthy R, Thorley-Lawson D: All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of Rat-1 fibroblasts. Journal of Virology 67:1638, 1993
26. Fennewald S, van Santen V, Kieff E: Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol 51:411, 1984
27. Liebowitz D, Wang D, Kieff E: Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J Virol 58:233, 1986
28. Hammerschmidt W, Sugden B, Baichwal V: The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J Virol 63:2469, 1989
29. Izumi K, Kaye K, Kieff E: Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation. J Virol 68:4369, 1994
30. Chen M, Tsai C, Liang C, Shu C, Hang C, Sulitzeanu D, Liu S, Chang Y: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131, 1992
31. Hu L, Chen F, Zheng F, Ernberg I, Cao S, Christensson B, Klein G, Winberg G: Clonability and tumorigenicity of human epithelial cells expressing the EBV-encoded membrane protein LMP1. Oncogene 8:1575, 1993
32. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt B, Delsol G, Pallesen G: Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937, 1993
33. Sandvej K, Peh S, Andresen B, Pallesen G: Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84:4053, 1994
34. Santon E, Manzanal AI, Campo E, Bellas C: Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. J Clin Pathol: Mol Pathol 48:M184, 1995
35. Hudson G, Farrell P, Barrell B: Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J Virol 53:528, 1985
36. Frizzera G: Atypical lymphoproliferative disorders, in Knowles D (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkins, 1992, p 459
37. Anonymous National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49:2112, 1982
38. Medeiros L, van Krieken J, Jaffe E, Raffeld M: Association of bcl-1 rearrangments with lymphocytic lymphoma of intermediate differentiation. Blood 10:2086, 1990
39. Lin J, Lin S, De B, Chan W, Evatt B: Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3, and EBER): Predominance of type A virus associated with Hodgkin's disease. Blood 81:3372, 1993
40. Martin J, Sugden B: Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association. J Virol 65:3246, 1991
41. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE: Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552, 1995
42. Zimber U, Adldinger H, Lenoir G: Geographical prevalence of two types of Epstein-Barr virus. Virology 154:56, 1986
43. Sixbey J, Shirley P, Chesney P, Buntin D, Resnick L: Detection of a second widespread strain of Epstein-Barr virus. Lancet 30:761, 1989
44. Goldschmidts W, Bhatia K, Johnson J, Akar N, Gutierrez M, Shibata D, Carolan M, Levine A, Magrath I: Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas. Leukemia 6:875, 1992
45. Frank D, Cesarman E, Liu Y, Michler R, Knowles D: Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 85:1396, 1995